mezlocillin has been researched along with cefepime in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Appleman, MD; Baker, FJ; Berne, TV; Gill, MA; Heseltine, PN; Holcomb, C; Okamoto, MP; Yellin, AE | 1 |
Bennion, RS; Hopkins, JA; Lally, KP; Roettger, R; Thompson, JE; Wilson, SE | 1 |
2 trial(s) available for mezlocillin and cefepime
Article | Year |
---|---|
A randomized study of cefepime versus the combination of gentamicin and mezlocillin as an adjunct to surgical treatment in patients with acute cholecystitis.
Topics: Acute Disease; Adult; Aged; Cefepime; Cephalosporins; Chemotherapy, Adjuvant; Cholecystitis; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Mezlocillin; Middle Aged; Treatment Outcome | 1993 |
Cefepime for infections of the biliary tract.
Topics: Adult; Bacterial Infections; Biliary Tract Diseases; Cefepime; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Mezlocillin; Middle Aged; Prospective Studies; Treatment Outcome | 1993 |
4 other study(ies) available for mezlocillin and cefepime
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |